Do CROs Need To Reinvent Themselves In 2025? A Deep Dive With Greg Licholai And Derk Arts

Contract Research Organizations (CROs) are at a critical juncture in their development. Faced with economic pressures, evolving regulatory landscapes, and rapid technological advancements, these organizations must reassess and redefine their value propositions to stay competitive. During a recent LinkedIn Live session, Greg Licholai, Chief Medical and Innovation Officer at ICON, and Derk Arts, CEO of Castor, delved into a crucial topic: the necessity for CROs to reinvent themselves in 2025.

Licholai and Arts discussed how economic constraints are pushing CROs to optimize their operations and find more cost-effective solutions without compromising quality. Regulatory shifts, including stricter compliance requirements and new guidelines, are compelling these organizations to adapt quickly to remain compliant and efficient. Additionally, technological advancements such as artificial intelligence, machine learning, and digital health tools are transforming the way CROs conduct research, manage data, and interact with stakeholders.

Access the full article to learn why CROs must be willing to reinvent themselves in 2025 and beyond.